Cleveland Heart, Inc. has partnered with the Cleveland Clinic to develop the next generation of mechanical cardiac circulatory assist devices with the potential to provide a complete range of treatment options for patients suffering from irreversible end-stage heart failure.
Heart failure is a terminal disease affecting over 20 million patients worldwide. Approximately 1 million patients suffer from Class IV heart failure, the end stage of the disease. LVADs are used to bridge patients until a donor heart becomes available (Bridge-to-Transplant therapy) or, increasingly,
as a long-term alternative to transplantation
(Destination Therapy.)
Learn More About the SmartHeart LVAD
What is a Left Ventricular Assist Device?
The left ventricle is the large, muscular chamber of the heart that pumps blood out to the body. A left ventricular assist device (LVAD) is a battery-operated, mechanical pump-type device that's surgically implanted. It helps maintain the pumping ability of a heart that can't
effectively work on its own.
Read More >>
Cleveland Heart News and Events
Heart and Lung Transplant Pioneer will Head Cardiac Surgery at The University of Maryland
Bartley P. Griffith, M.D., an internationally known heart surgeon who has pioneered lung and heart transplantation, has become head of the Division of Cardiac Surgery at the University of Maryland School of Medicine and chief of Cardiac Surgery at the University of Maryland Medical Center.
Read More >>
Cleveland Heart Innovation
Overview
A key feature of our technology platform is the ability to miniaturize the pump mechanism without an expectation that clinical performance of
the system will be compromised.
Read More >>
